Literature DB >> 32284542

Loss of ELF5-FBXW7 stabilizes IFNGR1 to promote the growth and metastasis of triple-negative breast cancer through interferon-γ signalling.

Sushil Kumar1, Ratnesh Kumar Srivastava1, Snahlata Singh1, Ajeya Nandi1, Gatha Thacker1, Hemma Murali1, Sabrina Kim1, Mary Baldeon1, John Tobias2, Mario Andres Blanco1, Rizwan Saffie2, M Raza Zaidi3, Satrajit Sinha4, Luca Busino2, Serge Y Fuchs1, Rumela Chakrabarti5.   

Abstract

Triple-negative breast cancer (TNBC) is characterized by a high degree of immune infiltrate in the tumour microenvironment, which may influence the fate of TNBC cells. We reveal that loss of the tumour suppressive transcription factor Elf5 in TNBC cells activates intrinsic interferon-γ (IFN-γ) signalling, promoting tumour progression and metastasis. Mechanistically, we find that loss of the Elf5-regulated ubiquitin ligase FBXW7 ensures stabilization of its putative protein substrate IFN-γ receptor 1 (IFNGR1) at the protein level in TNBC. Elf5low tumours show enhanced IFN-γ signalling accompanied by an increase of immunosuppressive neutrophils within the tumour microenvironment and increased programmed death ligand 1 expression. Inactivation of either programmed death ligand 1 or IFNGR1 elicited a robust anti-tumour and/or anti-metastatic effect. A positive correlation between ELF5 and FBXW7 expression and a negative correlation between ELF5, FBXW7 and IFNGR1 expression in the tumours of patients with TNBC strongly suggest that this signalling axis could be exploited for patient stratification and immunotherapeutic treatment strategies for Elf5low patients with TNBC.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32284542      PMCID: PMC8237104          DOI: 10.1038/s41556-020-0495-y

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  64 in total

Review 1.  Epithelial-mesenchymal transitions in tumour progression.

Authors:  Jean Paul Thiery
Journal:  Nat Rev Cancer       Date:  2002-06       Impact factor: 60.716

Review 2.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

3.  NCCN Guidelines Insights: Breast Cancer, Version 1.2017.

Authors:  William J Gradishar; Benjamin O Anderson; Ron Balassanian; Sarah L Blair; Harold J Burstein; Amy Cyr; Anthony D Elias; William B Farrar; Andres Forero; Sharon Hermes Giordano; Matthew P Goetz; Lori J Goldstein; Steven J Isakoff; Janice Lyons; P Kelly Marcom; Ingrid A Mayer; Beryl McCormick; Meena S Moran; Ruth M O'Regan; Sameer A Patel; Lori J Pierce; Elizabeth C Reed; Kilian E Salerno; Lee S Schwartzberg; Amy Sitapati; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; George Somlo; Melinda Telli; John H Ward; Dorothy A Shead; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2017-04       Impact factor: 11.908

4.  Long-term human CD34+ stem cell-engrafted nonobese diabetic/SCID/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells.

Authors:  Maya C André; Annika Erbacher; Christian Gille; Vanessa Schmauke; Barbara Goecke; Alexander Hohberger; Philippa Mang; Ayline Wilhelm; Ingo Mueller; Wolfgang Herr; Peter Lang; Rupert Handgretinger; Udo F Hartwig
Journal:  J Immunol       Date:  2010-07-28       Impact factor: 5.422

Review 5.  Humanized NOD-SCID IL2rg–/– mice as a preclinical model for cancer research and its potential use for individualized cancer therapies.

Authors:  Qianjun Zhou; John Facciponte; Min Jin; Qiang Shen; Qiang Lin
Journal:  Cancer Lett       Date:  2014-03-01       Impact factor: 8.679

6.  Multicolor flow cytometric analysis of immune cell subsets in tumor-bearing mice.

Authors:  Lauren J Bayne; Robert H Vonderheide
Journal:  Cold Spring Harb Protoc       Date:  2013-10-01

Review 7.  Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.

Authors:  Robert D Schreiber; Lloyd J Old; Mark J Smyth
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

8.  Cancer-Associated Fibroblasts Correlate with Tumor-Associated Macrophages Infiltration and Lymphatic Metastasis in Triple Negative Breast Cancer Patients.

Authors:  Jing Zhou; Xiao-Hua Wang; Yi-Xin Zhao; Cheng Chen; Xin-Yun Xu; Qi Sun; Hong-Yan Wu; Ming Chen; Jian-Feng Sang; Lei Su; Xiao-Qiao Tang; Xian-Biao Shi; Yin Zhang; Qiao Yu; Yong-Zhong Yao; Wei-Jie Zhang
Journal:  J Cancer       Date:  2018-11-24       Impact factor: 4.207

Review 9.  The clinical promise of immunotherapy in triple-negative breast cancer.

Authors:  Praveen Vikas; Nicholas Borcherding; Weizhou Zhang
Journal:  Cancer Manag Res       Date:  2018-12-10       Impact factor: 3.989

10.  Repeated observation of breast tumor subtypes in independent gene expression data sets.

Authors:  Therese Sorlie; Robert Tibshirani; Joel Parker; Trevor Hastie; J S Marron; Andrew Nobel; Shibing Deng; Hilde Johnsen; Robert Pesich; Stephanie Geisler; Janos Demeter; Charles M Perou; Per E Lønning; Patrick O Brown; Anne-Lise Børresen-Dale; David Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 12.779

View more
  23 in total

Review 1.  Recent Insight on Regulations of FBXW7 and Its Role in Immunotherapy.

Authors:  Liangliang Xing; Leidi Xu; Yong Zhang; Yinggang Che; Min Wang; Yongxiang Shao; Dan Qiu; Honglian Yu; Feng Zhao; Jian Zhang
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

Review 2.  Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression.

Authors:  Zimam Mahmud; Atiqur Rahman; Israt Dilruba Mishu; Yearul Kabir
Journal:  Cancer Metastasis Rev       Date:  2022-03-21       Impact factor: 9.237

Review 3.  Roles of IFN-γ in tumor progression and regression: a review.

Authors:  Dragica Jorgovanovic; Mengjia Song; Liping Wang; Yi Zhang
Journal:  Biomark Res       Date:  2020-09-29

4.  Breast-Specific Molecular Clocks Comprised of ELF5 Expression and Promoter Methylation Identify Individuals Susceptible to Cancer Initiation.

Authors:  Masaru Miyano; Rosalyn W Sayaman; Sundus F Shalabi; Parijat Senapati; Jennifer C Lopez; Brittany Lynn Angarola; Stefan Hinz; Arrianna Zirbes; Olga Anczukow; Lisa D Yee; Mina S Sedrak; Martha R Stampfer; Victoria L Seewaldt; Mark A LaBarge
Journal:  Cancer Prev Res (Phila)       Date:  2021-06-17

5.  A 2-Gene Signature Related to Interferon-Gamma Predicts Prognosis and Responsiveness to Immune Checkpoint Blockade of Glioma.

Authors:  Yongzhe Li; Hang Ji; Xin Gao
Journal:  Front Med (Lausanne)       Date:  2022-04-15

6.  Loss of Fbxw7 triggers mammary tumorigenesis associated with E2F/c-Myc activation and Trp53 mutation.

Authors:  Alison E Meyer; Quinlan Furumo; Cary Stelloh; Alex C Minella; Sridhar Rao
Journal:  Neoplasia       Date:  2020-11       Impact factor: 5.715

Review 7.  Neutrophils in cancer: heterogeneous and multifaceted.

Authors:  Catherine C Hedrick; Ilaria Malanchi
Journal:  Nat Rev Immunol       Date:  2021-07-06       Impact factor: 53.106

Review 8.  Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response.

Authors:  Michelle von Locquenghien; Catalina Rozalén; Toni Celià-Terrassa
Journal:  J Clin Invest       Date:  2021-01-04       Impact factor: 14.808

9.  Downregulation of miR-182-5p inhibits the proliferation and invasion of triple-negative breast cancer cells through regulating TLR4/NF-κB pathway activity by targeting FBXW7.

Authors:  Xingping Wu; Hao Chen; Miantao Wu; Songguo Peng; Lin Zhang
Journal:  Ann Transl Med       Date:  2020-08

Review 10.  Neutrophils: Orchestrators of the Malignant Phenotype.

Authors:  Brian E Hsu; Yunyun Shen; Peter M Siegel
Journal:  Front Immunol       Date:  2020-08-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.